Company Overview
Team Members
Technologies
Email Formats
Competitors
Faqs

10 free leads on us

Use our Chrome Extension & instantly connect with prospects

Download Free
Use Google
crystals

Find Contacts

Homepage  >  Business Services  > 

Exoxemis

Company Name

Exoxemis

Main Industry

Business Services

Website

www.exoxemis.com

Contact Information

Little Rock, Arkansas Office

111 Center St Ste 1616, Little Rock, Arkansas, 72201, United States

(501) 375-0940

Omaha, Nebraska Office

6029 N 16th St, Omaha, Nebraska, 68110, United States

(402) 884-2316

Little Rock, Arkansas Office

PO Box 7570, Little Rock, Arkansas, 72217, United States

(501) 375-0940

Exoxemis Profile and History

Exoxemis, Inc. (Little Rock, Arkansas) presents research results comparing the Myeloperoxidase (MPO) Enzyme System to antibiotics for irrigation of implant material at the Orthopaedic Research Society (ORS), San Francisco, CA, March 7 - 10, 2004. Residual bacteria at the site of implant surgery can lead to acute and delayed infection. Recent studies conducted by Exoxemis, Inc. clearly demonstrated that the MPO enzyme system rapidly and completely kills residual S. aureus, even in the presence of implant material. Antibiotic solutions traditionally used in the clinic failed to do so, and in fact showed re-growth of the initial inoculum. Dr. Anthony Robins, a co-investigator and orthopedic surgeon at University of Washington (Seattle, Washington) commented, "This new method demonstrates superiority over the current clinical practice in vitro for reducing residual bacteria." Exoxemis, Inc. (Little Rock, Arkansas), a biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections, and to address the growing problem of microbial drug resistance. The Exoxemis technology is a versatile platform that can be leveraged into multiple product areas, including medical, biodefense, industrial, veterinary and agricultural applications. For further information, contact medinfo@exoxemis.com. Read excerpts from reports about Exoxemis in the news.

...Read More

Exoxemis Inc

Exoxemis

Exoxemis, Inc (w)

Revenue

$3.9 M

Employees

20

Founded

1987

Exoxemis Executive Team & Key Decision Makers

Name & TitleContact Info
Angie Stephens
Angie Stephens

Chief Financial Officer

❅❅❅❅@exoxemis.com

(501) ❅❅❅-❅❅❅❅

Visit Profile

Steven Weintz
Steven Weintz

Business Development Vice President, Communications

❅❅❅❅@exoxemis.com

(843) ❅❅❅-❅❅❅❅

Visit Profile

Barbara Tobichuk
Barbara Tobichuk

Director, Clinical Operations

Visit Profile

Top Exoxemis Integrations and Technologies

Here's a list of some of the top trending technologies and APIs used by Exoxemis.

Frameworks and Libraries

(3 Technologies)

Web Analytics

(2 Technologies)

E-Commerce Platforms

(2 Technologies)

Search Marketing

(2 Technologies)

Programming Languages

(2 Technologies)

Exoxemis Email Formats

ParameterSample EmailPercentage

Exoxemis Top Competitors

CompanyEmployeesRevenueTop technologies
AB Science SA

AB Science SA

n/a$1.7 M
Pinnacle Biologics Inc

Pinnacle Biologics Inc

26$5.7 M
NeuTec Pharma PLC

NeuTec Pharma PLC

n/a$9 M
Pepgen Inc

Pepgen Inc

31$6.6 M
Active Biotech AB

Active Biotech AB

n/a$2.2 M

What is Exoxemis revenue?

Exoxemis revenue is $3.9 M

How many employees does Exoxemis have?

Exoxemis has 20 employees

What are Exoxemis’s primary industries?

Exoxemis’s main industries are: Business Services, Research & Development

What are some additional names or alternative spellings that users use while searching for Exoxemis?

Exoxemis appears in search results as Exoxemis Inc, Exoxemis, Exoxemis, Inc (w)